
























Submitted in partial fulfillment of the requirements 
for the degree of Master of Science in Chemistry 
in the Graduate College of the  























 1,3-Amino alcohols are common motifs in a variety of biologically active molecules 
including antivirals, antibiotics, antifungals, and various alkaloids. Due to their prevalence and 
utility as synthetic intermediates, a variety of methods have been developed to access these 
motifs in a diastereoselective fashion, which are outlined in detail herein. 
 This thesis documents a novel approach to access anti-1,3-amino alcohols through an 
intramolecular palladium (II)/sulfoxide-oxazoline catalyzed C—H functionalization between a 
terminal olefin and an N-tosyl carbamate, generating anti-1,3-oxazinanones. These motifs can be 
further elaborated upon, making this method ideal for the late stage diversification of complex 
molecules and pharmaceuticals. This new method can be carried out in the presence of reactive 
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CHAPTER 1: INTRODUCTION 
 
Chiral 1,3-amino alcohols are prevalent structural motifs in a variety of pharmaceutically 
active molecules and natural products including lopinavir (an antiretroviral), negamycin (an 
antibiotic), nikkomycin Z (an antifungal), ritronavir (an antiviral), Allosedridine (a Sedum 
alkaloid), and sedamine (a sedum alkaloid) (Figure 1).1 In addition to their biological activity, 
1,3-amino alcohols have been used as chiral ligands, resolving agents, and phase transfer 
catalysts.2 
A classic approach to synthesize 1,3-amino alcohols is by diastereoselective reduction of 
β-amino ketones or β-hydroxy imines, yielding the corresponding syn- or anti-1,3-amino alcohol. 
In 2002, the Ellman group reported that chiral t-butylsulfinyl imines 1 can be metallated to form 
enamine equivalents 2, which serve as competent nucleophiles when reacting with aldehydes, 
furnishing β-hydroxy imines 3 with good yields and high diastereoselectivity (Scheme 1).3 
Ellman further elaborated that addition product 3 could be hydrolyzed under acidic conditions 
giving chiral β-hydroxy ketones 4 with quantitative yields and no erosion in enantiomeric purity 
upon deprotection (Scheme 1). Ellman also reported that β-hydroxy imines 3 could undergo 
highly diastereoselective reductions using catecholborane or LiBHEt3 yielding the syn- and anti-
diastereomers 5 respectively with high levels of diastereoselectivity and synthetically useful 
yields (Scheme 1). This report marked the first stereoselective synthesis of both anti- and syn-
1,3-amino alcohols from a common synthetic intermediate. 
The usefulness of Ellman’s chiral t-butylsulfinyl auxiliary was demonstrated by the Xu 
group in the formal synthesis of (-)-pinidinol and (+)-epipinidinol (Scheme 2).4 Aldehyde 6 was 
reacted with (R)-p-toluenesulfinamide to generate oxo-sulfinimine 7. The addition of 7 to a 
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potassium Weinreb amide enolate furnished N-sulfinyl β-amino Weinreb amide 8, which was 
converted to β-amino ketone 9 with the addition of 5 equivalents of methylmagnesium bromide. 
Diastereoselective reduction of 9 using LiBEt3H generated anti-1,3-amino alcohol 10, which was 
further elaborated to synthesize (-)-pinidinol in 6 steps from 7 with 42% overall yield. The 
diastereoselective reduction of 9 with Li(t-BuO)3AlH furnished syn-1,3-amino alcohol 11, which 
was converted into (+)-epipinidinol in 6 steps from 7 with 36% overall yield. 
Although diastereoselective reductions demonstrate an efficient way to generate 1,3-
amino alcohols, the β-amino ketone or β-hydroxy imine precursors often require significant 
synthetic overhead, with a series of oxidation state manipulations. The use of enolate chemistry 
throughout these processes limit the tolerance for electrophilic functionality and require de novo 
synthesis in order to be applied to complex molecules. One approach to circumvent these 
limitations is by using transition metal catalyzed reactions to access 1,3-amino alcohol motifs. 
One strategy is the late stage installation of an amine using an intramolecular metallonitrene with 
an oxygen tether.  
The Du Bois group has shown that 1,3-amino alcohols can be accessed directly from C—
H bonds by utilizing a sulfamate ester 12, a dirhodium carboxylate catalyst, and PhI(OAc)2 to 
form a highly reactive rhodium nitrene (Scheme 3).5 In nearly all cases, the syn diasteromer 13 is 
the major product. The high reactivity of these species often presents challenges such as low 
site/chemoselectivity. In 2015, our group reported a manganese t-butylphthalocyanine catalyst 
capable of aminating a wide range of C—H bonds with greater reactivity and chemoselectivity 
than previous nitrene-based systems (Scheme 3).6 Although this method has been shown to be 
suitable for the late stage diversification of functionally dense complex molecules, it is highly 
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selective for the syn-diastereomer, leaving the anti-diastereomer inaccessible by nitrene based 
methods. 
The diastereoselectivity observed in these nitrene based C—H amination methods can be 
explained by considering a 6 membered ring transition state (Figure 2).7 In this transition state, 
the substituents are oriented in the pseudoequatorial positions in order to minimize A1,3-strain, 
resulting in the formation of the syn-diastereomer. When N-Boc sulfamides 13 are used instead 
of sulfamate esters 12, the anti-product is formed preferentially. This result supports the chairlike 
transition state, since the A1,3-strain between the N-Boc group and the α-substituent forces the 
substituent into the pseudoaxial position, favoring the anti-diastereomer.  
In addition to aza-aldol and nitrene based systems, allylic substitution reactions provide 
another approach to access 1,3-amino alcohol motifs. The Gu group demonstrated that 1,3-amino 
alcohol derivatives could be accessed via a Pd0 mediated allylic substitution reaction using 
homoallylic trichloroacetimidates 14 (Scheme 4).8 In this case the syn-diastereomer is always 
formed as the major product and high diastereoselectivity is only achieved when there is 
significant steric bulk adjacent to the trichloroacetimidate. The substrate scope is limited to 
simple substituted aryl rings and alkyl chains 
The Robiette group reported a diastereoselective Tsuji-Trost type cyclization of chiral 
dicarbamates 15 to give access to enantioenriched 1,3-amino alcohol precursors 16 (Scheme 5).9 
They found that the reaction initially favors the kinetic syn-diasteromer 17 and isomerizes over 
time to the thermodynamically favorable anti-product 16.  
Although allylic substitution reactions can access syn-1,3-amino alcohols, the 
corresponding anti-diastereomers are accessible for only sterically unhindered molecules with an 
isomerization event that often has very long reaction times. These methods are also limited by 
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the necessity for preinstalling a stereodefined allylic leaving group, which is often not trivial.10 
These limitations make these methods unpractical for the late stage diversification of highly 
functionalized complex molecules.  
Recently, the Breit group reported an intramolecular diastereoselective and 
stereodivergent rhodium-catalyzed coupling of sulfonylcarbamates to terminal allenes 18, giving 
access to both syn- 19 and anti-1,3-oxazinanones 20 (Scheme 6).1 The proposed catalytic cycle 
(Figure 3) suggests that in the syn conditions, pyridinium p-toluenesulfonate (PPTS) initiates the 
catalytic cycle by generating rhodium hydride 21, which then undergoes hydrometallation of the 
allene 18, forming rhodium-allyl 22. Subsequent inner-sphere reductive elimination forms the 
new C—N bond irreversibly, giving rise to the syn-product 19. When a carboxylic acid is used 
instead of PPTS in the anti-conditions, the carboxylate ligand is coordinated to the RhIII center. 
This prevents the coordination of RhIII to the carbamate, and instead forms species 23, forcing an 
outer-sphere attack on the π-allyl. The mechanism was supported by demonstrating that when the 
syn-product 19 is subjected to the anti-conditions, an inversion of relative configuration was 
observed, indicating that the reaction switches from kinetic to thermodynamic control. 
The authors highlighted the usefulness of these allylsulfonylcarbamates as synthetic 
intermediates by demonstrating a wide range of transformations (Scheme 7). They reported that 
the terminal olefin 24 could undergo metathesis furnishing 25 with 67% yield, and 9:1 E/Z 
selectivity, hydrogenation delivering 26 in 99%, or hydroformylated, giving 27 in 93% yield, 
with a linear to branched ratio of 95:5 respectively. The group also showed that bifunctional 
derivatization could be accomplished by hydride reduction to alcohol 28, cleaving the tosyl 
group under reductive conditions to the carbamate 29, or removal of both the carbamate and 
tosyl group, generating the corresponding 1,3-amino alcohol 30. 
5 
 
This impressive method outlines the usefulness of the products formed, however the 
synthetic overhead required to form the allene substrates is undesirable and limits the 
functionality that can be introduced due to the highly reactive nature of allenes.11 Additionally, 
since the allenes are generated via a sigmatropic rearrangement reaction from propargyl alcohol, 
this method has no way of introducing substitution in between the allene and the oxygen tether. 
A method that could access the same allylic amine products directly from the terminal olefin 
would eliminate these limitations, since terminal olefins are less reactive than allenes, and are 
widely prevalent feedstock chemicals Such a method would suitable for the late-stage 
diversification of complex molecules since it would limit the synthetic overhead and potentially 
allow access to nucleophilic functionality, such as alcohols and amines, that would not be 
tolerated by the allene functional group.  
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CHAPTER 1 FIGURES AND SCHEMES 
 
Figure 1. Biologically active molecules containing the chiral 1,3-amino alcohol motif  
 




Scheme 2. Formal synthesis of (-)-pinidinol and (+)-epipinidinol 
 




Figure 2. Diastereoselectivity in nitrene based C—H amination methods 
 
Scheme 4. Allylic substitution reaction using homoallylic trichloroacetimidates 
 




Scheme 6. Stereodivergent rhodium-catalyzed coupling of sulfonylcarbamates to allenes 
Figure 3. Proposed catalytic cycle for rhodium-catalyzed coupling 
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Scheme 7. Diversification of allylsulfonylcarbamates 
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CHAPTER 2: DEVELOPMENT OF C-H AMINATION METHOD 
 
Previously, our group reported the synthesis of syn-1,3-amino alcohols via 
palladium(II)/bis-sulfoxide catalyzed allylic C—H amination.12 Although this transformation 
demonstrated a wide functional group tolerance, an efficient method to access the anti- 
diastereomer remained elusive. This can be explained by considering the catalytic cycle (Figure 
4). In this transformation, the labile nature of the bis-sulfoxide ligand makes the system difficult 
to tune, since it is bound to the PdII during the C—H cleavage step, but not during the 
functionalization step, resulting in limited control of the diastereoselectivity of the reaction. 
Recently, our group has demonstrated that sulfoxide-oxazoline (SOX) ligands overcome 
many of these challenges because the sulfoxide group promotes C—H cleavage and the donating 
nature of the oxazoline are thought to promote the functionalization step, allowing for access to 
ligands that remain coordinated to Pd throughout the catalytic cycle. The versatility and 
tunability of this ligand class has been demonstrated in the enantioselective synthesis of 
isochromans13 and the construction of linear allylic amines14 via C—H functionalization of 
terminal olefins (Figure 5). 
 We envisioned that employing the SOX ligand platform, instead of the bis-sulfoxide 
ligand used in our previous system, would allow for tunable control over the the 
functionalization step, potentially allowing us to access to the anti-diastereomer, which is 
thermodynamically favored by ~2 kcal/mol.9 In the reaction of carbamate 31 to form 32, we 
found that for electron deficient SOX ligands, the syn-diastereomer is favored, however, 
switching to an electron-rich SOX ligand causes the thermodynamic anti-product to be 
predominately formed (Figure 6). 
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 This divergent diastereoselectivity can be explained by the following mechanistic scheme 
(Figure 7). First, PdII coordinates to the terminal olefin 33, and undergoes C—H cleavage, 
generating acetic acid and a cationic PdII π-allyl species 34, which then undergoes a reductive 
elimination event with the carbamate to form the new C—N bond, resulting in the kinetic syn-
product 35 and Pd0(SOX). At this point, Pd0 can either undergo oxidation to PdII by 
benzoquinone and acetic acid and re-enter the catalytic cycle, or Pd0(SOX) can bind to olefin 35 
and undergo an allylic substitution reaction to form another PdII π-allyl, which is followed by a 
subsequent reductive elimination event to form the thermodynamic anti-diastereomer 36.9 
We found that the electronics of the ligand used can be attributed to the observed 
diastereoselectivity, since electron-rich ligands create a more nucleophilic Pd0(SOX) complex, 
which increases the rate of the allylic substitution, relative to the rate of reoxidation to PdII. In 
our previous system, the reoxidation of Pd0 to PdII is facile, since the benzoquinone oxidant is 
already bound to Pd0 prior to the functionalization step. In the new system, benzoquinone is not 
bound to PdII during the functionalization step, which likely slows the rate of reoxidation and 
promotes the Pd0(SOX) mediated isomerization event. Currently, mechanistic studies are 
ongoing in order to elucidate the mechanism of this transformation. 
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CHAPTER 2 FIGURES 
 
Figure 4. syn-1,3-amino alcohols via palladium(II)/bis-sulfoxide catalyzed C—H amination 




Figure 6. Effect of the ligand on the diastereoselectivity 
 




CHAPTER 3: SCOPE OF C-H AMINATION METHOD 
 
With our best conditions in hand, we sought to seek out the generality of this reaction 
with respect to the substrate (Figure 8). We found that as the steric bulk around the carbamate 
increases, the yield and the diastereoselectivity increases (32, 37, 38, 39). This indicates that this 
method is practical for the late stage diversification of complex molecules, since they are often 
quite sterically hindered, and would likely undergo this reaction with high diastereoselectivity 
We discovered that the amination tolerates a variety of aryl substituents (40-46) however, the 
diastereoselectivity was higher for electron withdrawing moieties. Interestingly, aryl halides 
were well tolerated, with the aryl bromide 44 and aryl chloride 45 giving 59% and 67% yield 
respectively. This result is particularly useful since aryl bromides are known to readily undergo 
oxidative addition in the presence of Pd0, which can cause problems in systems that access these 
motifs using allylic substitution chemistry. In the case of aryl bromide 44, no side-products were 
observed, indicating that our proposed Pd0(SOX) mediated isomerization is likely much faster 
than the rate of the competing oxidative addition pathway. Critically, the aryl bromide can be 
used as a synthetic handle for further chemicals manipulations.  
Due to their prevalence in a variety of medicinally active molecules, the heterocycle 
tolerance of this reaction was explored. A tosyl-protected indole was well tolerated under our 
reaction conditions, generating 47 with 74% isolated yield of the anti-diastereomer. In the case 
of imidazole 48, only recovered starting material was observed with no benzoquinone conversion 
observed. One possibility is that the free nitrogen of the imidazole binds to the palladium, 
potentially forming a stable chelate which is detrimental to the catalytic cycle. Gratifyingly, a 
benzothiophene containing substrate was successfully aminated, furnishing 49 with 58%. In this 
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case, no recovered starting material was observed, and extended reaction time showed no benefit 
to product yield, indicating that the chelation of the sulfur atom in the heterocycle is likely not an 
issue. For the furan 50, decomposition was observed by 1H NMR, with no observable product. 
However, switching to a benzofuran, product 51 was obtained with 54% yield. These 
heterocycles demonstrate that oxygen, nitrogen, and sulfur heterocycles can be tolerated in this 
reaction, making it an appealing method for the late stage diversification of pharmaceuticals.  
We were pleased to find that alkynes were well tolerated in this reaction, generating 52 
with 72% yield since alkynes are known to undergo reactions with Pd(II) such as 
aminopalladation. No side products were observed in our case. A TBS- protected alcohol was 
used to generate 53 with 72% yield. Surprisingly, when the corresponding unprotected alcohol 
was subjected to the reaction conditions, 54 was obtained with 74% yield. This shows that 
protecting groups for alcohols are unncecssary under our reaction conditions, even for 
unhindered primary alcohols. For free alcohol 54, no extended reaction time was required, 
indicating that chelation to Pd was not a significant problem. Additionally,a Pd(II) mediated 
oxidation of the free alcohol was not observed under our conditions, even with extended reaction 
times of up to three days. 
This method represents a new stereodivergent approach to access both syn- and anti-1,3-
amino alcohols from terminal olefins with good yields and diastereoselectivity. This method 
allows for access to functional groups that are problematic for existing methods, such as 
unprotected alcohols and aryl bromides. The wide functional group tolerance and high 
diastereoselectivity for sterically congested substrates make this method appealing for the late 
stage diversification of complex molecules. 
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General Procedure for the synthesis of bis-homoallylic N-tosyl carbamates: 
A flame dried 100 mL round bottom flask filled with argon was charged with a stir bar, 
homoallylic alcohol (10 mmol), and THF (10 mL). The flask was cooled to 0 °C and p-
toluenesulfonyl isocyanate (12 mmol) was added dropwise. The mixture was stirred for 30 min 
and then quenched with saturated ammonium chloride. The mixture was diluted with ethyl 
acetate (50 mL) and washed once with brine (50 mL). The organic layer was dried over MgSO4, 
filtered, and concentrated in vacuo. Purification by flash chromatography (15% acetone/hexanes) 





hex-5-en-2-yl tosylcarbamate. Product obtained as a white solid. 1H NMR (500 MHz, 
Chloroform-d) δ 7.91 (d, J = 8.3 Hz, 2H), 7.37 (s, 1H), 7.34 (d, J = 7.7 Hz, 2H), 5.70 (ddt, J = 
17.2, 10.6, 6.6 Hz, 1H), 4.94 (dq, J = 7.4, 1.6 Hz, 1H), 4.92 (t, J = 1.4 Hz, 1H), 4.85 – 4.75 (m, 
1H), 2.45 (s, 3H), 1.96 (tdt, J = 8.0, 6.6, 1.5 Hz, 2H), 1.69 – 1.58 (m, 1H), 1.58 – 1.49 (m, 1H), 
1.18 (d, J = 6.3 Hz, 3H). 13C NMR (126 MHz, Chloroform-d) δ 150.1, 145.1, 137.4, 135.8, 
129.7, 129.7, 128.5, 128.5, 115.3, 74.5, 34.9, 29.5, 21.8, 19.9. HRMS (ESI) m/z calculated for 





2-methylhept-6-en-3-yl tosylcarbamate. Product obtained as a white solid. 1H NMR (500 
MHz, Chloroform-d) δ 7.90 (d, J = 8.4 Hz, 2H), 7.68 (s, 1H), 7.33 (d, J = 8.4 Hz, 2H), 5.64 (ddt, 
J = 16.9, 10.4, 6.6 Hz, 1H), 4.92 – 4.88 (m, 1H), 4.86 (dq, J = 11.3, 1.5 Hz, 1H), 4.63 (dt, J = 
7.1, 5.4 Hz, 1H), 2.43 (s, 3H), 1.88 – 1.73 (m, 3H), 1.56 – 1.46 (m, 2H), 0.81 (dd, J = 8.6, 6.8 
Hz, 6H). 13C NMR (126 MHz, Chloroform-d) δ 150.7, 145.1, 137.6, 136.0, 129.7, 129.7, 128.4, 
128.4, 115.1, 82.2, 31.6, 30.2, 29.6, 21.8, 18.3, 17.5. HRMS (ESI) m/z calculated for 








1-phenylhept-6-en-3-yl tosylcarbamate. Product obtained as a white solid. 1H NMR (500 
MHz, Chloroform-d) δ 7.96 (d, J = 8.4 Hz, 2H), 7.69 (br s, 1H), 7.36 (d, J = 8.1 Hz, 2H), 7.27 
(dd, J = 8.3, 6.8 Hz, 2H), 7.23-7.16 (m, 1H), 7.08 (dd, J = 7.0, 1.8, 2H), 5.77-5.64 (m, 1H), 4.96-
4.90 (m, 2H), 4.85 (tt, J = 7.2, 5.2 Hz, 1H), 2.50 (ddd, J = 9.4, 7.0, 3.0 Hz, 2H), 2.44 (s, 3H), 
1.99-1.92 (m, 1H), 1.83 (tdd, J = 7.6, 6.0, 4.1 Hz, 2H), 1.73-1.56 (m, 1H). 13C NMR (126 MHz, 
Chloroform-d) δ 150.4, 145.2, 141.2, 137.3, 135.9, 129.7 (2C), 128.6 (2C), 128.5 (2C), 128.3 
(2C), 126.1, 115.3, 77.4, 35.7, 33.2, 31.4, 29.3, 21.8. HRMS (ESI) m/z calculated for 





1-phenylpent-4-en-1-yl tosylcarbamate. Product obtained as a white solid.. 1H NMR (500 
MHz, Chloroform-d) δ 7.90 (d, J = 8.4 Hz, 2H), 7.69 (br s, 1H), 7.31 (d, J = 8.1 Hz, 2H), 7.31-
7.26 (m, 3H), 7.19-7.13 (m, 2H), 5.70 (ddt, J = 16.7, 10.5, 6.3 Hz, 1H), 5.61 (dd, J = 7.4, 6.1 Hz, 
1H), 4.95 (dt, J = 4.3, 1.5 Hz, 1H), 4.92 (dq, J = 12.6, 1.5 Hz, 1H), 2.44 (s, 3H), 2.04-1.87 (m, 
3H), 1.86-1.76 (m, 1H). 13C NMR (126 MHz, Chloroform-d) δ 149.9, 145.1, 139.1, 137.0,135.8, 
129.7, 129.7, 128.6, 128.6, 128.5, 128.5, 128.4, 126.5, 126.5, 115.6, 79.1, 35.3, 29.5, 21.8. 





1-(naphthalen-2-yl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white solid. 1H 
NMR (500 MHz, Chloroform-d) δ 7.89 (d, J = 8.4 Hz, 2H), 7.82 – 7.77 (m, 1H), 7.77 – 7.72 (m, 
2H), 7.61 (s, 1H), 7.51 – 7.45 (m, 2H), 7.29 – 7.26 (m, 1H), 7.25 (d, J = 8.2 Hz, 2H), 5.81 – 5.68 
(m, 2H), 4.98 – 4.91 (m, 2H), 2.39 (s, 3H), 2.10 – 2.00 (m, 1H), 2.02 – 1.87 (m, 3H). 13C NMR 
(126 MHz, Chloroform-d) δ 150.2, 145.1, 137.0 (2C), 136.5, 135.8, 133.3, 133.1, 129.7 (2C), 
128.6, 128.4 (2C), 128.2, 127.8, 126.4, 126.4, 125.9, 123.9, 79.2, 35.2, 29.5, 21.7 (one signal 
presumed to be obscured by solvent). HRMS (ESI) m/z calculated for C23H23NO4S [M+Na]+: 





1-(4-methoxyphenyl)pent-4-en-1-yl tosylcarbamate. Product obtained as a yellow oil. 1H 
NMR (500 MHz, Chloroform-d) δ 7.88 (d, J = 8.4 Hz, 2H), 7.60 (br s, 1H), 7.31 (d, J = 7.8 Hz, 
2H), 7.10 (d, J = 8.7 Hz, 2H), 6.81 (d, J = 8.7 Hz, 2H), 5.70 (ddt, J = 16.8, 10.4, 6.4 Hz, 1H), 
5.56 (t, J = 6.9 Hz, 1H), 4.97-4.93 (m, 1H), 4.93-4.88 (m, 1H), 3.78 (s, 3H), 2.44 (s, 3H), 2.01-
1.85 (m, 3H), 1.78 (ddt, J = 11.6, 7.0, 5.9 Hz, 1H). 13C NMR (126 MHz, Chloroform-d) δ 159.7, 
149.9, 145.1, 137.1, 135.8, 131.1, 129.7, 129.7, 128.4, 128.4, 128.1, 128.1, 115.6, 114.0, 114.0 






1-(p-tolyl)pent-4-en-1-yl tosylcarbamate. Product obtained as an off-white solid. 1H NMR 
(500 MHz, Chloroform-d) δ 7.90 (d, J = 8,4 Hz, 2H), 7.86 (br s, 1H), 7.31 (d, J = 8.1 Hz, 2H), 
7.09 (d, J = 8.0 Hz, 2H), 7.05 (d, J = 8.0 Hz, 2H), 5.71 (ddt, J = 16.6, 10.4, 6.2 Hz, 1H), 5.58 (t, 
J = 6.6 Hz, 1H), 5.01-4.82 (m, 2H), 2.44 (s, 3H), 2.32 (s, 3H), 2.06-1.88 (m, 3H), 1.83-1.73 (m, 
1H). 13C NMR (126 MHz, Chloroform-d) δ 150.0, 145.0, 138.2, 137.1, 136.1, 135.8, 129.7, 
129.7, 129.3, 129.3, 128.4, 128.4, 126.5, 126.5, 115.5, 79.0, 35.2, 29.5, 21.8, 21.3. HRMS (ESI) 





1-(4-bromophenyl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white solid. 1H NMR 
(500 MHz, Chloroform-d) δ 7.88 (d, J = 8.3 Hz, 2H), 7.44 (br s, 1H),  7.41 (d, J = 8.5 Hz, 2H), 
7.32 (d, J = 8.0 Hz, 2H), 7.03 (d, J = 8.4 Hz, 2H), 5.69 (ddt, J = 16.5, 10.4, 6.3 Hz, 1H), 5.54 
(dd, J = 7., 6.0 Hz, 1H), 4.97-4.88 (m, 2H), 2.45 (s, 3H), 1.96-1.87 (m, 3H), 1.81-1.73 (m, 1H). 
13C NMR (126 MHz, Chloroform-d) δ 149.7, 145.3, 138.2, 136.8, 135.7, 131.9(2C), 129.8(2C), 
128.4(2C), 128.2(2C), 122.5, 115.9, 78.3, 35.1, 29.4, 21.9 HRMS (ESI) m/z calculated for 






1-(4-chlorophenyl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white solid. 1H NMR 
(500 MHz, Chloroform-d) δ 8.32 (s, 1H), 7.88 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.1 Hz, 2H), 7.23 
(d, J = 8.5 Hz, 2H), 7.08 (d, J = 8.5 Hz, 2H), 5.68 (ddt, J = 16.5, 10.3, 6.2 Hz, 1H), 5.57 (dd, J = 
7.5, 5.9 Hz, 1H), 5.00 – 4.85 (m, 2H), 2.44 (s, 3H), 1.97 – 1.81 (m, 3H), 1.82 – 1.69 (m, 1H). 13C 
NMR (126 MHz, Chloroform-d) δ 150.1, 145.2, 137.7, 136.8, 135.6, 134.1, 129.7, 129.7, 128.7, 
128.7, 128.3, 128.3, 127.8, 127.8, 115.7, 78.1, 35.1, 29.3, 21.8. HRMS (ESI) m/z calculated for 





1-(4-(trifluoromethyl)phenyl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white 
solid. 1H NMR (500 MHz, Chloroform-d) δ 8.25 (br s, 1H), 7.90 (d, J = 8.4 Hz, 2H), 7.52 (d, J = 
8.1 Hz, 2H), 7.31 (d, J = 8.1 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 5.76-5.58 (m, 2H), 4.95 (dd, J = 
10.3, 1.6 Hz, 1H), 4.94-4.89 (m, 1H), 2.44 (s, 3H), 2.00-1.85 (m, 3H), 1.86-1.71 (m, 1H). 13C 
NMR (126 MHz, Chloroform-d) δ 150.0, 145.3, 143.3, 143.3, 136.7, 134.4 (q, J = 130.44 Hz), 
129.8(2C), 128.4(2C), 126.6(2C), 125.6 (q, J = 3.7 Hz, 2C), 124.0 (q, J = 272.2 Hz), 115.9, 78.0, 
35.3, 27.3, 21.7. 19F NMR (470 MHz, Chloroform-d) δ -62.65. HRMS (ESI) m/z calculated for 





(S)-1-(1-tosyl-1H-indol-5-yl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white solid. 
1H NMR (500 MHz, Chloroform-d) δ 7.92 – 7.80 (m, 4H), 7.76 (d, J = 8.4 Hz, 2H), 7.56 (d, J = 
3.6 Hz, 1H), 7.32 (d, J = 1.6 Hz, 1H), 7.26 (d, J = 8.0 Hz, 1H), 7.22 (d, J = 7.8 Hz, 1H), 7.11 (dd, 
J = 8.7, 1.7 Hz, 1H), 6.57 (dd, J = 3.7, 0.8 Hz, 1H), 5.73 – 5.60 (m, 2H), 4.94 – 4.86 (m, 2H), 
2.41 (s, 3H), 2.33 (s, 3H), 1.99 – 1.92 (m, 1H), 1.88 (q, J = 6.9 Hz, 2H), 1.83 – 1.70 (m, 1H). 13C 
NMR (126 MHz, Chloroform-d) δ 150.0, 145.3, 145.1., 137.0, 135.6, 135.2, 134.5, 134.3, 130.8, 
130.1, 130.1, 129.7, 129.7, 128.4, 128.4, 127.0, 126.9, 126.9, 123.0, 119.6, 115.6, 113.6, 109.0, 
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79.1, 35.4, 29.5, 21.8, 21.7. HRMS (ESI) m/z calculated for C28H28N2O3S2 [M+Na]+: 575.1287, 





1-(benzo[b]thiophen-5-yl)pent-4-en-1-yl tosylcarbamate. Product obtained as a white solid. 
1H NMR (500 MHz, Chloroform-d) δ 7.88 (d, J = 8.4 Hz, 2H), 7.78 (d, J = 8.3 Hz, 1H), 7.61 (d, 
J = 1.6 Hz, 1H), 7.45 (d, J = 5.4 Hz, 1H), 7.29 – 7.24 (m, 3H), 7.14 (dd, J = 8.4, 1.7 Hz, 1H), 
5.79 – 5.66 (m, 2H), 4.96 (dt, J = 3.3, 1.4 Hz, 1H), 4.93 (dq, J = 11.6, 1.5 Hz, 1H), 2.41 (s, 3H), 
2.08 – 1.99 (m, 1H), 1.98 – 1.92 (m, 2H), 1.91 – 1.82 (m, 1H). 13C NMR (126 MHz, 
Chloroform-d) δ 149.9, 145.0, 139.7, 139.6, 136.9, 135.7, 135.3, 129.6, 129.6, 128.3, 128.3, 
127.2, 123.8, 122.7, 122.6, 121.7, 115.5, 79.2, 35.3, 29.5, 21.7 HRMS (ESI) m/z calculated for 





1-(benzofuran-5-yl)pent-4-en-1-yl tosylcarbamate. Product obtained as a yellow solid. 1H 
NMR (500 MHz, Chloroform-d) δ 7.88 (d, J = 8.4 Hz, 2H), 7.60 (s, 1H), 7.54 – 7.50 (m, 1H), 
7.42 (dd, J = 8.2, 0.9 Hz, 1H), 7.30 (ddd, J = 8.4, 7.3, 1.3 Hz, 1H), 7.25 – 7.20 (m, 3H), 6.63 (s, 
1H), 5.83 (t, J = 7.1 Hz, 1H), 5.73 (ddt, J = 17.8, 9.4, 6.5 Hz, 1H), 4.98 (t, J = 1.4 Hz, 1H), 4.96 
– 4.93 (m, 1H), 2.37 (s, 3H), 2.14 – 2.06 (m, 2H), 2.05 – 1.95 (m, 2H). 13C NMR (126 MHz, 
Chloroform-d) δ 154.9, 153.2, 149.8, 145.2, 136.6, 135.4, 129.7, 129.7, 128.5, 128.5, 127.6, 
125.0, 123.1, 121.5, 116.0, 111.5, 106.1, 71.8, 31.4, 29.3, 21.8. HRMS (ESI) m/z calculated for 





9-(triisopropylsilyl)non-1-en-8-yn-5-yl tosylcarbamate. Product obtained as an off-white 
solid. 1H NMR (500 MHz, Chloroform-d) δ 7.90 (d, J = 8.4 Hz, 2H), 7.42 (s, 1H), 7.34 (d, J = 
8.1 Hz, 2H), 5.67 (ddt, J = 18.1, 9.6, 6.5 Hz, 1H), 4.95 – 4.91 (m, 1H), 4.91 – 4.88 (m, 1H), 4.85 
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(p, J = 6.2 Hz, 1H), 2.44 (s, 3H), 2.13 (tt, J = 9.4, 4.7 Hz, 2H), 1.96 – 1.87 (m, 2H), 1.79 – 1.71 
(m, 2H), 1.67 – 1.56 (m, 2H), 1.08 – 0.96 (m, 21H). 13C NMR (126 MHz, Chloroform-d) δ 
150.1, 145.2, 137.2, 135.7, 129.7, 129.7, 128.4, 128.4, 115.4, 107.2, 81.2, 76.9, 33.2, 32.9, 29.3, 
21.8, 18.7, 18.7, 18.7,. 18.7, 18.7, 18.7, 16.0, 11.3, 11.3, 11.3. HRMS (ESI) m/z calculated for 





9-((tert-butyldimethylsilyl)oxy)non-1-en-5-yl tosylcarbamate. Product obtained as a colorless 
oil solid. 1H NMR (500 MHz, Chloroform-d) δ 7.90 (d, J = 8.3 Hz, 2H), 7.61 (br. s, 1H), 7.33 
(d, J = 7.9 Hz, 2H), 5.73 – 5.61 (m, 1H), 4.92 (dt, J = 2.5, 1.6 Hz, 1H), 4.89 (q, J = 1.6 Hz, 1H), 
4.76 (p, J = 6.3 Hz, 1H), 3.53 (t, J = 6.5 Hz, 2H), 2.44 (s, 3H), 1.95 – 1.84 (m, 2H), 1.61 – 1.53 
(m, 2H), 1.54 – 1.45 (m, 2H), 1.46 – 1.38 (m, 2H), 1.24 – 1.16 (m, 2H), 0.88 (s, 9H), 0.02 (s, 
6H). 13C NMR (126 MHz, Chloroform-d) δ 150.4, 145.1, 137.5, 135.8, 129.7, 129.7, 128.4, 
128.4, 115.2, 77.8, 77.4, 62.9, 33.7, 33.0, 32.6, 29.3, 26.1, 26.1, 26.1, 21.8, 21.4, 18.5, -5.2, -5.2 





9-hydroxynon-1-en-5-yl tosylcarbamate. Product obtained as a white solid. 1H NMR (500 
MHz, Chloroform-d) δ 7.89 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 5.72 – 5.60 (m, 1H), 
4.93 – 4.89 (m, 1H), 4.89 – 4.84 (m, 1H), 4.81 – 4.72 (m, 1H), 3.57 (t, J = 6.4 Hz, 2H), 2.43 (s, 
3H), 1.92 – 1.82 (m, 2H), 1.63 – 1.39 (m, 6H), 1.31 – 1.18 (m, 2H). 13C NMR (126 MHz, 
Chloroform-d) δ 150.8, 145.0, 137.4, 135.9, 129.6, 129.6, 128.4, 128.4, 115.2, 77.5, 62.5, 33.6, 
33.0, 32.3, 29.4, 21.8, 21.2. HRMS (ESI) m/z calculated for C17H25NO5S [M+H]+: 356.1532, 
found 356.1544. 
 
General Procedure for the Allylic Amination Reation: 
A 1 dram vial equipped with a magnetic stir bar was charged with Pd(OAc)2 (4.5 mg, 0.02 
mmol, 0.1 equiv), (±)-OMe SOX (6.9 mg, 0.02 mmol, 0.1 equiv.), 2,5-dimethylbenzoquinone 
(32.7 mg, 0.24 mmol, 1.2 equiv.), N-tosyl carbamate (0.2 mmol, 1 equiv.), and 1,2-
dichloroethane (0.3 mL, 0.66 M). The vial was sealed with a Teftlon lined cap and stirred in an 
aluminum heating block at 45 °C for 24 h. The solution was allowed to cool to room temperature 
and then filtered through a short silica gel plug, rinsed with 20 mL Et2O, and transferred to a 125 
mL separatory funnel. The organic layer was washed with aqueous sodium bisulfite (2 x 15 mL) 
and 1M NaOH (2 x 15 mL). The solvent was removed via rotary evaporation and the resulting 
solid was purified by flash chromatography (100 mL SiO2, 10-30% gradient EtOAc/hexanes 





(±)-(4S,6S)-6-cyclopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one (38). Racemic carbamate (64.7 
mg, 0.20 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-30% gradient EtOAc/hexanes) afforded the anti- diastereomer as a yellow 
oil (50.2 mg, 0.156 mmol, 78%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 7.91 (d, 
J = 8.4 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.84 (ddd, J = 17.0, 10.5, 4.9 Hz, 1H), 5.37 (dd, J = 
10.5, 1.5 Hz, 1H), 5.32 (dd, J = 17.1, 1.7 Hz, 1H), 5.22-5.17 (m, 1H), 3.64 (ddd, J = 10.9, 8.5, 
3.8 Hz, 1H), 2.42 (s, 3H), 2.17-2.04 (m, 2H), 0.98 (qt, J = 8.2, 4.8, 1H), 0.62 (tdd, J = 8.2, 5.8, 
4.7 Hz, 1H), 0.56 (tdd, J = 8.7, 5.7, 4.6 Hz, 1H), 0.46-0.40 (m, 1H), 0.24-0.15 (m, 1H). 13C 
NMR (126 MHz, Chloroform-d) δ 148.5, 145.1, 135.7, 135.6, 129.5, 129.5, 129.3, 129.3, 118.7, 
80.6, 56.1, 33.1, 21.8, 14.9, 3.7, 2.1. HRMS (ESI) m/z calculated for C16H21NO4S [M-H]+: 





(±)-(4S,6S)-6-isopropyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one (32). Racemic carbamate (65.1 mg, 
0.20 mmol) was reacted according to the general procedure Purification by flash chromatography 
(10-20% gradient EtOAc/hexanes) afforded the anti- diastereomer as a white solid (52.3 mg, 
0.162 mmol, 81%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 7.90 (d, J = 8.5 Hz, 
2H), 7.29 (d, J = 8.1 Hz, 2H), 5.88 (ddd, J = 17.1, 10.5, 5.0 Hz, 1H), 5.40 (dd, J = 10.5, 1.5 Hz, 
1H), 5.34 (dd, J = 17.1, 1.7 Hz, 1H), 5.21 (dtd, J = 3.9, 2.5, 1.3 Hz, 1H), 4.11 (ddd, J = 11.8, 6.2, 
3.2 Hz, 1H), 2.41 (s, 3H), 2.12-1.86 (m, 2H), 1.81 (dq, J = 13.4, 6.7 Hz, 1H), 0.94 (d, J = 6.8 Hz, 
3H), 0.90 (d, J = 6.9 Hz, 3H). 13C NMR (126 MHz, Chloroform-d) δ 148.6, 144.9, 135.6, 129.4, 
129.4, 129.2, 129.2, 118.6, 80.3, 56.0, 32.1, 29.9, 21.7, 17.7, 17.5. HRMS (ESI) m/z calculated 





(±)-(4S,6R)-6-phenethyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one (39). Racemic carbamate (77.5 
mg, 0.20 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-20% gradient EtOAc/hexanes) afforded the anti- diastereomer as a white 
solid (53.8 mg, 0.140 mmol, 70%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 7.93 
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(d, J = 8.4 Hz, 2H),  7.32 (d, J = 8.2 Hz, 2H), 7.30-7.25 (m, 2H), 7.23-7.17 (m, 1H), 7.15 (d, J = 
7.2 Hz, 2H), 5.87 (ddd, J = 17.1, 10.5, 5.0 Hz, 1H), 5.39 (dd, J = 10.0, 1.5 Hz, 1H), 5.32 (dd, J = 
15.8, 1.7 Hz, 1H), 5.21 (ddt, J = 6.2, 4.8, 2.0, 1H), 4.20 (ddt, J = 11.8, 8.0, 4.0 Hz, 1H), 2.81 
(ddd, J = 13.9, 9.8, 5.5 Hz 1H), 2.68 (ddd, J = 13.8, 9.5, 6.7 Hz, 1H), 2.44 (s, 3H), 2.06-1.92 (m, 
3H), 1.84 (dddd, J = 14.2, 9.8, 6.7, 4.5 Hz, 1H). 13C NMR (126 MHz, Chloroform-d) δ 148.5, 
145.1, 140.6, 135.6, 129.5, 129.5, 129.3, 129.3, 128.6, 128.6, 128.4, 128.4, 126.3, 118.7, 75.0, 
56.2, 36.8, 32.9, 31.0, 21.8. HRMS (ESI) m/z calculated for C21H23NO4S [M+H]+: 386.1426, 





(±)-(4S,6S)-6-phenyl-3-tosyl-4-vinyl-1,3-oxazinan-2-one (40). Racemic carbamate (71.8 mg, 
0.20 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-20% gradient EtOAc/hexanes) afforded the anti- diastereomer as an off-
white solid (59.7 mg, 0.166 mmol, 83%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 
7.95 (d, J = 8.5 Hz, 2H), 7.42-7.27 (m, 7H), 6.02 (ddd, J = 17.1, 10.5, 4.8 Hz, 1H), 5.51 (dd, J = 
10.6, 1.5 Hz, 1H), 5.46 (dd, J = 17.1, 1.7 Hz, 1H), 5.39 (t, J = 7.6 Hz, 1H), 5.29 (ddt, J = 5.0, 3.5, 
2.2 Hz, 1H), 2.44 (s, 3H), 2.30-2.21 (m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 148.4, 
145.3, 137.7, 135.5, 129.6, 129.6, 129.4, 129.4, 129.0, 128.9, 128.9, 125.9, 125.9, 119.1, 77.0, 






(±)-(4S,6S)-6-(naphthalen-2-yl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (41). Racemic carbamate 
(81.9 mg, 0.20 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as a white 
solid (54.1 mg, 0.133 mmol, 67%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 7.97 
(d, J = 8.4 Hz, 2H), 7.87 – 7.73 (m, 4H), 7.55 – 7.44 (m, 2H), 7.38 – 7.30 (m, 3H), 6.07 (ddd, J = 
17.1, 10.6, 4.8 Hz, 1H), 5.59 – 5.53 (m, 2H), 5.51 (dd, J = 17.1, 1.6 Hz, 1H), 5.35 – 5.30 (m, 
1H), 2.45 (s, 3H), 2.37 – 2.28 (m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 148.5, 145.3, 
135.6, 135.1, 133.5, 133.2, 129.7, 129.7, 129.4, 129.4, 128.9, 128.2, 127.9, 126.8, 126.8, 125.2, 
123.2, 119.2, 77.1, 56.4, 35.4, 21.9 (one signal missing, assumed to be obscured by solvent 






(±)-(4S,6S)-6-(4-methoxyphenyl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (42). Racemic carbamate 
(77.8 mg, 0.200 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as a white 
solid (53.5 mg, 0.138 mmol, 69%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d2) δ 7.94 
(d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.1 Hz, 2H), 7.20 (d, J = 8.7 Hz, 2H), 6.86 (d, J = 8.8 Hz, 2H), 
6.00 (ddd, J = 17.1, 10.5, 4.8 Hz, 1H), 5.49 (dd, J = 10.6, 1.5 Hz, 1H), 5.45 (dd, J = 17.1, 1.6 Hz, 
1H), 5.33 (dd, J = 11.7, 3.4 Hz, 1H), 5.30 – 5.25 (m, 1H), 3.79 (s, 3H), 2.44 (s, 3H), 2.32 – 2.17 
(m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 160.14, 148.51, 145.19, 135.60, 129.7,129.6, 
129.6, 129.4, 129.4, 127.5, 127.5, 119.0, 114.2, 114.2, 76.9, 56.4, 55.4, 35.0, 21.8. HRMS (ESI) 





(±)-(4S,6S)-6-(p-tolyl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (43). Racemic carbamate (74.7 mg, 
0.200 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as an off-
white solid (61.7 mg, 0.150 mmol, 75%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 
7.95 (d, J = 8.4 Hz, 2H), 7.32 (d, J = 8.6, 2H), 7.19 – 7.14 (m, 4H), 6.01 (ddd, J = 17.1, 10.5, 4.9 
Hz, 1H), 5.51 (dd, J = 10.6, 1.5 Hz, 1H), 5.46 (dd, J = 17.1, 1.6 Hz, 1H), 5.35 (dd, J = 10.8, 4.3 
Hz, 1H), 5.28 (tdt, J = 4.8, 3.2, 1.6 Hz, 1H), 2.44 (s, 3H), 2.34 (s, 3H), 2.29 – 2.19 (m, 2H). 13C 
NMR (126 MHz, Chloroform-d) δ 148.5, 145.2, 139.0, 135.7, 135.6, 134.8, 129.7, 129.7, 129.5, 
129.5, 129.4, 129.4, 125.9, 125.9, 119.1, 77.0, 56.4, 35.3, 21.9, 21.3. HRMS (ESI) m/z 





(±)-(4S,6S)-6-(4-bromophenyl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (44). Racemic carbamate 
(87.7 mg, 0.200 mmol) was reacted according to the general procedure. Purification by flash 
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chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as an off-
white solid (49.3 mg, 0.113 mmol, 57%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 
7.94 (d, J = 8.4 Hz, 2H), 7.49 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 7.7 Hz, 2H), 7.16 (d, J = 8.4 Hz, 
2H), 6.01 (ddd, J = 17.0, 10.5, 4.8 Hz, 1H), 5.52 (dd, J = 10.6, 1.5 Hz, 1H), 5.46 (dd, J = 17.1, 
1.7 Hz, 1H), 5.35 (dd, J = 11.0, 4.1 Hz, 1H), 5.29 (m, 1H), 2.45 (s, 3H), 2.27-2.14 (m, 2H). 13C 
NMR (126 MHz, Chloroform-d) δ 148.2, 145.4, 136.8, 135.4, 135.4, 132.1, 132.1, 129.7, 129.7, 
129.4, 129.4, 127.6, 127.6, 120.0, 119.3, 76.3, 56.3, 35.3, 21.9. HRMS (ESI) m/z calculated for 





(±)-(4S,6S)-6-(4-chlorophenyl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (45). Racemic carbamate 
(78.8 mg, 0.200 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as an off-
white solid (54.0 mg, 0.138 mmol, 69%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 
7.94 (d, J = 7.8 Hz, 2H), 7.35 – 7.30 (m, 4H), 7.22 (d, J = 8.3 Hz, 2H), 6.01 (ddd, J = 17.1, 10.6, 
4.7 Hz, 1H), 5.52 (d, J = 10.6 Hz, 1H), 5.46 (d, J = 17.2 Hz, 1H), 5.36 (dd, J = 10.8, 4.3 Hz, 1H), 
5.31 – 5.26 (m, 1H), 2.44 (s, 3H), 2.27 – 2.15 (m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 
148.3, 145.4, 136.2, 135.3, 134.9, 129.6, 129.6, 129.4, 129.4, 129.1, 129.1, 127.3, 127.3, 119.3, 
76.2, 56.3, 35.2, 21.9. (missing one signal, presumed to be obscured). HRMS (ESI) m/z 





(±)-(4S,6S)-3-tosyl-6-(4-(trifluoromethyl)phenyl)-4-vinyl-1,3-oxazinan-2-one (46). Racemic 
carbamate (85.5 mg, 0.200 mmol) was reacted according to the general procedure. Purification 
by flash chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as 
an off-white solid (43.7 mg, 0.103 mmol, 52%, [>20:1 anti:syn]): 1H NMR (500 MHz, 
Chloroform-d) δ 7.95 (d, J = 8.4 Hz, 2H), 7.62 (d, J = 8.2 Hz, 2H), 7.42 (d, J = 8.0 Hz, 2H), 7.33 
(d, J = 7.8 Hz, 2H), 6.03 (ddd, J = 17.2, 10.6, 4.8 Hz, 1H), 5.54 (dd, J = 10.5, 1.5 Hz, 1H), 5.51 – 
5.39 (m, 2H), 5.34 – 5.28 (m, 1H), 2.45 (s, 3H), 2.33 – 2.14 (m, 2H). 13C NMR (126 MHz, 
Chloroform-d) δ 148.1, 145.5, 141.8, 135.4, 135.3, 131.19 (q, J = 32.7 Hz), 129.7, 129.7, 129.5, 
129.5, 126.1, 126.1, 125.94 (q, J = 3.8 Hz), 125.94 (q, J = 3.8 Hz), 123.91 (q, J = 272.4 Hz), 






(±)-(4S,6S)-3-tosyl-6-(1-tosyl-1H-indol-5-yl)-4-vinyl-1,3-oxazinan-2-one (47). Racemic 
carbamate (110.3 mg, 0.200 mmol) was reacted according to the general procedure. Purification 
by flash chromatography (5-25% gradient acetone/hexanes) afforded the anti- diastereomer as an 
off-white solid (75.1 mg, 0.130 mmol, 65%, [>20:1 d.r.]): 1H NMR (500 MHz, Chloroform-d) δ 
7.94 (d, J = 8.4 Hz, 3H), 7.72 (d, J = 8.5 Hz, 2H), 7.56 (d, J = 3.7 Hz, 1H), 7.46 (d, J = 1.7 Hz, 
1H), 7.31 (d, J = 8.1 Hz, 2H), 7.23-7.13 (m, 3H), 6.59 (dd, J = 3.8, -.5 Hz, 1H), 6.01 (ddd, J = 
17.1, 10.6, 4.8 Hz, 1H), 5.50 (dd, J = 10.6, 1.5 Hz, 1H), 5.48-5.39 (m, 2H), 5.29 (dd, J = 3.1, 1.6 
Hz, 1H), 2.43 (s, 3H), 2.32 (s, 3H), 2.29-2.21 (m, 2H).  13C NMR (126 MHz, Chloroform-d) δ 
148.4, 145.3, 145.3, 135.5, 135.1, 134.9, 132.8, 131.0, 130.1, 130.1, 129.6, 129.6, 129.4, 129.4, 
127.4, 126.9, 122.5, 119.2, 113.9, 109.0, 77.2, 56.4, 35.4, 21.8, 21.7. HRMS (ESI) m/z 





(±)-(4S,6S)-6-(benzo[b]thiophen-5-yl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (49). Racemic 
carbamate (83.1 mg, 0.200 mmol) was reacted according to the general procedure. Purification 
by flash chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as 
an off-white solid (47.9 mg, 0.116 mmol, 58%, [>20:1 anti:syn]): 1H NMR (500 MHz, 
Chloroform-d) δ 7.96 (d, J = 8.4 Hz, 2H), 7.85 (d, J = 8.3 Hz, 1H), 7.77 (d, J = 1.7 Hz, 1H), 7.48 
(d, J = 5.4 Hz, 1H), 7.33 (d, J = 8.1 Hz, 2H), 7.30 (dd, J = 5.5, 0.8 Hz, 1H), 7.23 (dd, J = 8.4, 1.8 
Hz, 1H), 6.05 (ddd, J = 17.1, 10.6, 4.8 Hz, 1H), 5.57 – 5.44 (m, 3H), 5.34 – 5.29 (m, 1H), 2.45 
(s, 3H), 2.34 – 2.26 (m, 2H). 13C NMR (126 MHz, Chloroform-d) δ 148.5, 145.3, 140.2, 139.8, 
135.5, 135.5, 134.0, 129.6, 129.6, 129.4, 129.4, 127.8, 123.9, 123.0, 121.9, 121.1, 119.2, 77.4, 










(±)-(4S,6S)-6-(benzofuran-2-yl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (51). Racemic carbamate 
(79.9 mg, 0.200 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (10-25% gradient EtOAc/hexanes) afforded the anti- diastereomer as an off 
white solid (42.5 mg, 0.107 mmol, 54%, [>20:1 anti:syn]): 1H NMR (500 MHz, Chloroform-d) δ 
7.95 (d, J = 8.4 Hz, 2H), 7.55 (dd, J = 7.8, 0.6 Hz, 1H), 7.44 (dd, J = 8.3, 0.9 Hz, 1H), 7.36 – 
7.28 (m, 3H), 7.23 (td, J = 7.4, 1.0 Hz, 1H), 6.76 (s, 1H), 6.00 (ddd, J = 17.1, 10.6, 4.6 Hz, 1H), 
5.57 – 5.50 (m, 2H), 5.47 (dd, J = 17.1, 1.7 Hz, 1H), 5.40 – 5.35 (m, 1H), 2.62 (ddd, J = 14.3, 
12.3, 5.2 Hz, 1H), 2.44 (s, 3H), 2.37 (dt, J = 14.3, 2.9 Hz, 1H). 13C NMR (126 MHz, 
Chloroform-d) δ 155.1, 151.9, 147.7, 145.4, 135.3, 135.0, 129.6, 129.6, 129.4, 129.4, 127.4, 
125.4, 123.3, 121.7, 119.4, 111.6, 106.0, 71.0, 56.0, 31.4, 21.9. HRMS (ESI) m/z calculated for 






Racemic carbamate (98.4 mg, 0.20 mmol) was reacted according to the general procedure. 
Purification by flash chromatography (10-20% gradient EtOAc/hexanes) afforded the anti- 
diastereomer as an off-white solid (76.2 mg, 0.156 mmol, 78%, [>20:1 anti:syn]): 1H NMR (500 
MHz, Chloroform-d) δ 7.91 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.3 Hz, 2H), 5.87 (ddd, J = 17.1, 
10.5, 4.8 Hz, 1H), 5.42 – 5.33 (m, 2H), 5.22 (dp, J = 7.2, 2.0 Hz, 1H), 4.68 – 4.57 (m, 1H), 2.49 
– 2.43 (m, 1H), 2.43 (s, 3H), 2.36 (dt, J = 17.2, 6.1 Hz, 1H), 2.08 (dt, J = 14.1, 2.7 Hz, 1H), 1.96 
(ddd, J = 14.1, 12.0, 5.1 Hz, 1H), 1.88 (ddt, J = 14.3, 8.3, 6.0 Hz, 1H), 1.71 (dddd, J = 13.5, 8.7, 
6.1, 4.4 Hz, 1H), 1.07 – 0.94 (m, 21H). 13C NMR (126 MHz, Chloroform-d) δ 148.4, 145.2, 
135.5, 135.4, 129.6, 129.6, 129.3, 129.3, 118.9, 106.6, 81.9, 74.4, 56.2, 34.2, 32.8, 21.8, 18.8, 
18.8, 18.8, 18.8, 18.8, 18.8, 15.7, 11.3, 11.3, 11.3. HRMS (ESI) m/z calculated for 











(53). Racemic carbamate (93.9 mg, 0.20 mmol) was reacted according to the general procedure. 
Purification by flash chromatography (10-20% gradient EtOAc/hexanes) afforded the anti- 
diastereomer as an off-white solid (67.3 mg, 0.144 mmol, 72%, [>20:1 anti:syn]): 1H NMR (500 
MHz, Chloroform-d) δ 7.90 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.1 Hz, 2H), 5.88 (ddd, J = 17.1, 
10.5, 4.9 Hz, 1H), 5.40 (dd, J = 10.6, 1.5 Hz, 1H), 5.36 (dd, J = 17.1, 1.6 Hz, 1H), 5.21 – 5.16 
(m, 1H), 4.36 (dddd, J = 12.2, 7.8, 5.0, 2.9 Hz, 1H), 3.56 (t, J = 6.1 Hz, 2H), 2.41 (s, 3H), 2.01 
(dt, J = 14.2, 2.7 Hz, 1H), 1.91 (ddd, J = 14.1, 11.8, 5.2 Hz, 1H), 1.67 (dddd, J = 14.7, 7.6, 5.8, 
3.1 Hz, 1H), 1.59 – 1.51 (m, 1H), 1.51 – 1.42 (m, 3H), 1.42 – 1.31 (m, 1H), 0.86 (s, 9H), 0.01 (s, 
6H). 13C NMR (126 MHz, Chloroform-d) δ 148.6, 145.1, 135.7, 135.6, 129.5, 129.5, 129.3, 
129.3, 118.7, 75.8, 62.8, 56.2, 34.8, 32.8, 32.4, 26.1, 26.1, 26.1, 21.8, 21.1, 18.4, -5.2, -5.2. 





(±)-(4S,6R)-6-(4-hydroxybutyl)-3-tosyl-4-vinyl-1,3-oxazinan-2-one (54). Racemic carbamate 
(71.1 mg, 0.20 mmol) was reacted according to the general procedure. Purification by flash 
chromatography (30-60% gradient EtOAc/hexanes) afforded the anti- diastereomer as a white 
solid (51.7 mg, 0.146 mmol, 73%, [>20:1 anti:syn]).  1H NMR (500 MHz, Chloroform-d) δ 7.91 
(d, J = 8.4 Hz, 2H), 7.30 (d, J = 7.8 Hz, 1H), 5.88 (ddd, J = 17.1, 10.5, 4.9 Hz, 1H), 5.41 (dd, J = 
10.5, 1.5 Hz, 1H), 5.36 (dd, J = 17.1, 1.6 Hz, 1H), 5.23 – 5.15 (m, 1H), 4.38 (dddd, J = 11.9, 7.8, 
4.6, 3.0 Hz, 1H), 3.62 (t, J = 6.0 Hz, 2H), 2.42 (s, 3H), 2.04 – 1.99 (m, 1H), 1.94 (ddd, J = 14.2, 
11.7, 5.2 Hz, 1H), 1.74 – 1.64 (m, 1H), 1.64 – 1.47 (m, 4H), 1.46 – 1.36 (m, 1H). 13C NMR (126 
MHz, Chloroform-d) δ 148.6, 145.1, 135.7, 129.6, 129.6 129.3, 129.3, 118.8, 75.8, 62.6, 56.2, 
34.8, 32.9, 32.3, 21.8, 21.1. HRMS (ESI) m/z calculated for C17H23NO5S [M+H]+: 354.1375, 
found 354.1384.  
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